【ChiCTR-TRC-11001655】Electroacupuncture and Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Trial in Primary Care Setting
ChiCTR-TRC-11001655
结束
/
/
/
2011-11-04
/
/
Carpal Tunnel Syndrome
Electroacupuncture and Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Trial in Primary Care Setting
Electroacupuncture and Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Trial in Primary Care Setting
N
随机平行对照
Ⅲ期
Randomized
单盲
Health and Health Service Research Fund (HHSRF)
/
182
/
2012-04-01
1990-01-01
/
Patients aged 18-70 and fulfilling the Katz CTS hand diagram criteria of (1) Classic / Probable Symptoms or (2) Possible Symptoms. Eligible patients should also (3) have the ability to read and speak Chinese (Cantonese), and (4) agree to sign the Informed consent and (5) are willing to attend follow up and / or electroacupuncture sessions.；
请登录查看Patients with symptoms and signs of axonal loss and evident median nerve denervation, including (1) constant numbness, (2) loss of sensibility, and (3) thenar muscular atrophy or weakness will be excluded. Patients with secondary CTS caused by inflammatory arthropathy, coexisting cervical radical radiculopathy, polyneuropathy, diabetes mellitus, pregnancy, malignancy, hypothyroidism, alcoholism, rheumatoid arthritis, space-occupying lesions (tumours, hypertrophic synovial tissue, fracture callus, and osteophytes), infections, and familial neuropathy will also be excluded. In particular, cervical radiculopathy will be actively ruled out by assessing the existence of related symptoms and signs, including neck pain, reduced reflexes, less well demarcated dermatomal involvement, and positive Spurling's test. Patients who received previous carpal tunnel release surgery, or have used warfarin, oral steroid, local steroid injection, night splint or acupuncture for CTS in the past 6 months, or other serious illnesses will be considered as ineligible.；
请登录查看JC School of Public Health and Primary Care, The Chinese University of Hong Kong
/
JC School of Public Health and Primary Care, The Chinese University of Hong Kong的其他临床试验
- Effects of Behavioural Activation With Mindfulness and Physical Exercise (BAMPE) on Mental Health: A Randomized Controlled Trial
- Effects of stand-alone mindfulness practices for people with long COVID-19 symptoms: A randomized controlled trial
- 慢性腰背痛症者對靜觀治療的支付意願和偏好
- Online integrated mindfulness-meaning programme for depression and anxiety during COVID-19: A pilot randomized controlled trial
- 專科門診病人經驗調查 2018/19
- A randomized, controlled clinical trial: The effects of mindfulness-based cognitive therapy on chronic insomnia among Chinese patients in the community
- Electroacupuncture and Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Trial in Primary Care Setting
JC School of Public Health and Primary Care, The Chinese University of Hong Kong的其他临床试验
- Personalised Lifestyle Medicine in Mid-life Project
- Effects of Behavioural Activation With Mindfulness and Physical Exercise (BAMPE) on Mental Health: A Randomized Controlled Trial
- Effects of stand-alone mindfulness practices for people with long COVID-19 symptoms: A randomized controlled trial
- 慢性腰背痛症者對靜觀治療的支付意願和偏好
- Online integrated mindfulness-meaning programme for depression and anxiety during COVID-19: A pilot randomized controlled trial
- 專科門診病人經驗調查 2018/19
- 對香港自閉症譜系兒童及其家庭進行正念訓練改善其健康狀况
- 正念认知疗法治疗自杀幸存者预试验
- 兩個临床證據質量評估工具的可靠性比較：隨機對照試驗
- 以社區為基礎的隊列研究 - 使用全自動視網膜圖像分析（ARIA）來評估中風風險與生活方式的關系
- Electroacupuncture and Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Trial in Primary Care Setting
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 60
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04